Home › Compare › PHH vs MRK

PHH vs MRK: Dividend Comparison 2026

PHH yields 519.48% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PHH wins by $82618.03M in total portfolio value
10 years
PHH
PHH
● Live price
519.48%
Share price
$0.39
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$82618.09M
Annual income
$59,925,648,245.24
Full PHH calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — PHH vs MRK

📍 PHH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPHHMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PHH + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PHH pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PHH
Annual income on $10K today (after 15% tax)
$44,155.84/yr
After 10yr DRIP, annual income (after tax)
$50,936,801,008.45/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, PHH beats the other by $50,936,792,411.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PHH + MRK for your $10,000?

PHH: 50%MRK: 50%
100% MRK50/50100% PHH
Portfolio after 10yr
$41309.07M
Annual income
$29,962,829,179.51/yr
Blended yield
72.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PHH
No analyst data
Altman Z
-47.9
Piotroski
4/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PHH buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPHHMRK
Forward yield519.48% ✓2.81%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$82618.09M ✓$57.7K
Annual income after 10y$59,925,648,245.24 ✓$10,113.78
Total dividends collected$80663.18M ✓$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PHH vs MRK ($10,000, DRIP)

YearPHH PortfolioPHH Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$62,648$51,948.05$11,213$373.04+$51.4K → PHH
2$371,187$304,153.67$12,667$512.06+$358.5K → PHH
3$2,081,374$1,684,203.51$14,439$708.14+$2.07M → PHH
4$11,053,153$8,826,082.71$16,640$988.16+$11.04M → PHH
5$55,631,534$43,804,660.58$19,432$1,394.07+$55.61M → PHH
6$265,575,168$206,049,427.30$23,057$1,992.90+$265.55M → PHH
7$1,203,458,668$919,293,238.21$27,889$2,894.79+$1203.43M → PHH
8$5,180,966,101$3,893,265,325.52$34,518$4,286.29+$5180.93M → PHH
9$21,207,890,565$15,664,256,836.91$43,912$6,494.35+$21207.85M → PHH
10$82,618,091,150$59,925,648,245.24$57,714$10,113.78+$82618.03M → PHH

PHH vs MRK: Complete Analysis 2026

PHH — Stock

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.

Full PHH Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PHH vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PHH vs SCHDPHH vs JEPIPHH vs OPHH vs KOPHH vs MAINPHH vs JNJPHH vs ABBVPHH vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.